It is also relevant to the clinical situation that Twist and Sox9 are often elevated in malignant ovarian tumors and Twist expression confers a poor outcome to the late stage ovarian cancer patient survival [19, 20]. This evidence concerns the gene TWIST1 and ovarian carcinoma.